GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (FRA:63E) » Definitions » FCF Margin %

Onward Medical NV (FRA:63E) FCF Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Onward Medical NV's Free Cash Flow for the six months ended in Jun. 2024 was €-14.83 Mil. Onward Medical NV's Revenue for the six months ended in Jun. 2024 was €0.00 Mil. Therefore, Onward Medical NV's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Onward Medical NV's current FCF Yield % is -13.77%.

The historical rank and industry rank for Onward Medical NV's FCF Margin % or its related term are showing as below:


FRA:63E's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -145.32
* Ranked among companies with meaningful FCF Margin % only.


Onward Medical NV FCF Margin % Historical Data

The historical data trend for Onward Medical NV's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Onward Medical NV FCF Margin % Chart

Onward Medical NV Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial - - - - -

Onward Medical NV Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Onward Medical NV's FCF Margin %

For the Biotechnology subindustry, Onward Medical NV's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Onward Medical NV's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's FCF Margin % falls into.



Onward Medical NV FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Onward Medical NV's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-32.692/0
= %

Onward Medical NV's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-14.829/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Onward Medical NV FCF Margin % Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Onward Medical NV Business Description

Traded in Other Exchanges
Address
High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE
Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injuries. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United States and four European markets: Germany, France, the UK, and the Netherlands to create a customer base.

Onward Medical NV Headlines

No Headlines